These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13790639)

  • 41. Split products of fibrin in human renal disease.
    Stiehm ER; Trygstad CW
    Am J Med; 1969 May; 46(5):774-86. PubMed ID: 4182522
    [No Abstract]   [Full Text] [Related]  

  • 42. Complement in human disease.
    Schur PH; Austen KF
    Annu Rev Med; 1968; 19():1-24. PubMed ID: 4871687
    [No Abstract]   [Full Text] [Related]  

  • 43. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiglobulins and human disease.
    Goldberg LS; Fudenberg HH
    Vox Sang; 1971 Jan; 20(1):1-6. PubMed ID: 4102241
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.
    Schroeter AL; Conn DL; Jordon RE
    Ann Rheum Dis; 1976 Aug; 35(4):321-6. PubMed ID: 970989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dynamics of the patient's proteinogram in rheumatoid arthritis and systemic lupus erythematosus as affected by hemosorption therapy].
    Dmitriev AA; Shevchenko OP; Petrunin DD
    Ter Arkh; 1984; 56(5):81-4. PubMed ID: 6463893
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduction of pleural fluid complement activity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Glovsky MM; Louie JS; Pitts WH; Alenty A
    Clin Immunol Immunopathol; 1976 Jul; 6(1):31-41. PubMed ID: 949879
    [No Abstract]   [Full Text] [Related]  

  • 48. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.
    HALL AP; BARDAWIL WA; BAYLES TB; MEDNIS AD; GALINS N
    N Engl J Med; 1960 Oct; 263():769-75. PubMed ID: 13710745
    [No Abstract]   [Full Text] [Related]  

  • 49. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
    Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement testing in the diagnosis of immune and autoimmune diseases.
    Schur PH
    Am J Clin Pathol; 1977 Nov; 68(5 Suppl):647-59. PubMed ID: 335876
    [No Abstract]   [Full Text] [Related]  

  • 51. [A CONCEPTION OF ISOIMMUNE DISEASES].
    SANDOR G
    Med Monde; 1964 Jun; 40():85-99. PubMed ID: 14177709
    [No Abstract]   [Full Text] [Related]  

  • 52. [Morphological differentiation of peripheral blood lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Brelińska-Peczalska R; Mackiewicz S
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1287-90. PubMed ID: 1161565
    [No Abstract]   [Full Text] [Related]  

  • 53. [The serum prolactin levels of men with systemic lupus erythematosus and rheumatoid arthritis].
    Folomeev MIu; Nasonov EL; Prokaeva TV; Masenko VP; Ovtrakht NV
    Ter Arkh; 1990; 62(1):62-3. PubMed ID: 2333620
    [No Abstract]   [Full Text] [Related]  

  • 54. Alpha-1-antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus.
    Karsh J; Vergalla J; Jones EA
    Arthritis Rheum; 1979 Feb; 22(2):111-3. PubMed ID: 311199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic tests of value in diagnosis. 2. Complement.
    Coffey RL; Zile MR; Luskin AT
    Postgrad Med; 1981 Aug; 70(2):183-8. PubMed ID: 7019873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [STUDIES ON THE DIFFERENTIAL DIAGNOSTIC VALUE OF COMPLEMENT DETERMINATION IN RHEUMATIC AND PARARHEUMATIC DISEASES].
    GEIDEL H; SELLE K; SCHABINSKI G
    Z Gesamte Inn Med; 1964 Jan; 19():68-73. PubMed ID: 14136179
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical significance of chronic biologic false positive Wassermann reaction and "antinuclear factors".
    Berglund S; Carlsson M
    Acta Med Scand; 1966 Oct; 180(4):407-12. PubMed ID: 5296985
    [No Abstract]   [Full Text] [Related]  

  • 59. [Behavior of complement in serum and synovial fluid in rheumatic diseases].
    Gangl A; Thumb N
    Wien Z Inn Med; 1968; 49(7):251-7. PubMed ID: 5737587
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.